Drug Interaction Study of Warfarin and MT-3995

NCT02531568 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Warfarin
DRUG: MT-3995

Sponsor

Tanabe Pharma Corporation